首页|辅酶Q10联合氟桂利嗪治疗偏头痛的临床疗效分析

辅酶Q10联合氟桂利嗪治疗偏头痛的临床疗效分析

扫码查看
目的 探究辅酶Q10联合氟桂利嗪治疗偏头痛的临床疗效。方法 选取2023年1-6月四川省绵阳市第三人民医院收治的104例偏头痛患者为研究对象,采用随机数字表法分为对照组和观察组,每组52例。对照组给予氟桂利嗪治疗,观察组给予辅酶Q10联合氟桂利嗪治疗,两组患者均连续治疗6个月。比较分析两组患者治疗6个月后的临床疗效以及两组患者治疗期间的不良反应发生情况。比较分析两组患者治疗前及治疗6个月后的脑血流动力学指标(大脑后动脉的平均血流速度、大脑中动脉的平均血流速度、大脑前动脉的平均血流速度)、氧化应激状态[氧磷酶-1(PON-1)、氧化型低密度脂蛋白(ox-LDL)、芳香酯酶(ArE)]、偏头痛症状[偏头痛发作持续时间、偏头痛疼痛程度、偏头痛发作频次],采用数字等级评定量表(NRS)评估两组患者的偏头痛疼痛程度。结果 治疗6个月后,观察组患者的临床总有效率高于对照组,差异有统计学意义(P<0。05)。两组患者治疗期间的不良反应总发生率比较差异无统计学意义(P>0。05)。治疗6个月后,两组患者大脑中动脉的平均血流速度、大脑前动脉的平均血流速度、大脑后动脉的平均血流速度、ox-LDL、偏头痛发作频次、偏头痛发作持续时间与治疗前比较均降低或缩短,且观察组低于或短于对照组,差异均有统计学意义(P<0。05)。治疗6个月后,两组患者的PON-1、ArE与治疗前比较均升高,且观察组高于对照组,差异均有统计学意义(P<0。05)。治疗前及治疗6个月后,两组患者的NRS评分比较差异均无统计学意义(P>0。05)。结论 辅酶Q10联合氟桂利嗪治疗偏头痛的临床疗效显著,可有效改善患者的脑血流动力学与氧化应激状态,且安全性较好。
Analysis of clinical efficacy of coenzyme Q10 combined with flunarizine in the treatment of migraine
Objective To explore the clinical efficacy of coenzyme Q10 combined with flunarizine in the treatment of migraine.Method A total of 104 migraine patients admitted to The Third Hospital of Mianyang in Sichuan Province from January to June 2023 were selected as the study objects.They were divided into control group and observation group by random number table method,with 52 cases in each group.The control group was treated with flunarizine,and the observation group was treated with coenzyme Q10 combined with flunarizine.Two groups were treated for 6 months.The clinical efficacy in the two groups after 6 months of treatment and the occurrence of adverse reactions between the two groups were compared and analyzed.Cerebral hemodynamic indexes(mean blood flow velocity of posterior cerebral artery,mean blood flow velocity of middle cerebral artery,mean blood flow velocity of anterior cerebral artery),stress response indexes(PON-1,ox-LDL,ArE),migraine symptoms(migraine attack duration,severity of pain,migraine attack frequency)in the two groups were compared and analyzed before and after treatment.NRS was used to assess the degree of migraine pain in two groups.Result After 6 months of treatment,the total clinical effective rate in the observation group was higher than that in the control group,and the difference was statistically significant(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups during treatment(P>0.05).After 6 months of treatment,the mean blood flow velocity of the middle cerebral artery,the mean blood flow velocity of the anterior cerebral artery,the mean blood flow velocity of the posterior cerebral artery,ox-LDL,migraine attack frequency and migraine attack duration in the two groups were all decreased or shortened compared with before treatment,and the observation group was lower or shorter than the control group,and the differences were statistically significant(P<0.05).After 6 months of treatment,PON-1 and ArE in two groups were higher than before treatment,and the observation group was higher than the control group,and the differences were statistically significant(P<0.05).There was no significant difference in NRS scores between the two groups before treatment and 6 months after treatment(P>0.05).Conclusion The combination of coenzyme Q10 and flunarizine in the treatment of migraine has a significant clinical effect,and can effectively improve the cerebral hemodynamics of patients,oxidative stress state,with good safety.

MigraineCoenzyme Q10FlunarizineCerebral hemodynamic

王丽波、肖黎黎、舒鑫、张弟文

展开 >

四川省绵阳市第三人民医院·四川省精神卫生中心,四川绵阳 621000

偏头痛 辅酶Q10 氟桂利嗪 脑血流动力学

四川省医学科研课题计划

S21A79

2024

中国医刊
人民卫生出版社

中国医刊

CSTPCD
影响因子:1.14
ISSN:1008-1070
年,卷(期):2024.59(9)